Launched from the ExploraMed incubator based in Mountain View, California, X9, Inc. is a privately held medical technology company focused on advancing vascular access and patient care in dialysis and ...

The ATEV™ was observed to have superior duration of use over 24 months compared to autogenous fistula in high-need subgroups with historically ...

For patients like Pham, Vantive’s home dialysis technologies represent more than medical equipment — they’re a pathway to a ...

The UK Hemodialysis Vascular Grafts Market offers growth opportunities despite AVF preference. Rising CKD/ESRD cases drive demand for reliable grafts, especially in elderly/high-risk patients.

A kidney trafficking racket centered around Madanapalle’s Global Hospital has sent shockwaves across the State, with police ...

Vijayawada: The state govt on Tuesday approved seven new dialysis centres, where Rs 75 lakh worth of dialysis equipment would be established at each centre. Each centre will have the capacity to ...

Procedure was carried out on a 34-year-old Pune resident and mother of three suffering from End-Stage Renal Disease ...

Venova Medical Announces First Subjects Enrolled in VENOS-3 Pivotal IDE Study of the Velocity (R) Percutaneous AVF System The Velocity System is a next generation percutaneous AVF technology designed ...

Merit Medical (Nasdaq:MMSI) announced that its application for reimbursement for its Wrapsody procedures requires further CMS ...

“Two-Year Outcomes in Female Patients from A Prospective Randomized Trial of Humacyte’s Acellular Tissue Engineered Vessel vs. Autologous Arteriovenous Fistula for Hemodialysis,” to be presented by ...

Humacyte, Inc. ( HUMA) Q3 2025 Earnings Call November 12, 2025 8:00 AM EST Good morning, ladies and gentlemen, and welcome to the Humacyte's Third Quarter Results Conference Call. [Operator ...